Robert Baffi, SVP, Technical Operations at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 9,228 shares at $31.46 ($292K) on 2008-07-30, disclosed to the SEC on 2008-07-31.
Scheduled sale ($292k) by SVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.04 | 28 | $869 | 0.3% |
| 2 | $31.05 | 100 | $3K | 1.1% |
| 3 | $31.08 | 100 | $3K | 1.1% |
| 4 | $31.15 | 200 | $6K | 2.1% |
| 5 | $31.24 | 500 | $16K | 5.3% |
| 6 | $31.30 | 100 |
| $3K |
| 1.1% |
| 7 | $31.33 | 100 | $3K | 1.1% |
| 8 | $31.35 | 200 | $6K | 2.1% |
| 9 | $31.36 | 100 | $3K | 1.1% |
| 10 | $31.37 | 100 | $3K | 1.1% |
| 11 | $31.46 | 66 | $2K | 0.7% |
| 12 | $31.47 | 200 | $6K | 2.2% |
| 13 | $31.49 | 100 | $3K | 1.1% |
| 14 | $31.51 | 600 | $19K | 6.5% |
| 15 | $31.51 | 200 | $6K | 2.2% |
| 16 | $31.56 | 100 | $3K | 1.1% |
| 17 | $31.57 | 300 | $9K | 3.2% |
| 18 | $31.63 | 234 | $7K | 2.5% |
| 19 | $31.65 | 100 | $3K | 1.1% |
| 20 | $31.68 | 200 | $6K | 2.2% |
| 21 | $31.69 | 100 | $3K | 1.1% |
| 22 | $31.78 | 600 | $19K | 6.5% |
| 23 | $31.79 | 400 | $13K | 4.3% |
| 24 | $31.82 | 550 | $18K | 6.0% |
| 25 | $31.84 | 200 | $6K | 2.2% |
| 26 | $31.85 | 200 | $6K | 2.2% |
| 27 | $31.89 | 200 | $6K | 2.2% |
| 28 | $31.90 | 3,100 | $99K | 33.8% |
| 29 | $31.91 | 250 | $8K | 2.7% |
| Total | $31.69 avg | 9,228 | $292K | 100% |
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |